Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis
Objective: To identify circulating microRNAs (miRNAs) linked to disease stage and disability
in multiple sclerosis (MS). Methods: Sera from 296 participants including patients with MS …
in multiple sclerosis (MS). Methods: Sera from 296 participants including patients with MS …
[HTML][HTML] Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis
K Regev, A Paul, B Healy, F von Glenn… - Neurology® …, 2016 - ncbi.nlm.nih.gov
Objective: To identify circulating microRNAs (miRNAs) linked to disease stage and disability
in multiple sclerosis (MS). Methods: Sera from 296 participants including patients with MS …
in multiple sclerosis (MS). Methods: Sera from 296 participants including patients with MS …
Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis
K Regev, A Paul, B Healy, F von Glenn… - Neurology® …, 2016 - dash.harvard.edu
Objective: To identify circulating microRNAs (miRNAs) linked to disease stage and disability
in multiple sclerosis (MS). Methods: Sera from 296 participants including patients with MS …
in multiple sclerosis (MS). Methods: Sera from 296 participants including patients with MS …
[引用][C] Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis
K Regev, A Paul, B Healy, F von Glenn… - Neurology …, 2016 - cir.nii.ac.jp
Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis
K Regev, A Paul, B Healy… - Neurology (R) …, 2016 - pubmed.ncbi.nlm.nih.gov
Objective To identify circulating microRNAs (miRNAs) linked to disease stage and disability
in multiple sclerosis (MS). Methods Sera from 296 participants including patients with MS …
in multiple sclerosis (MS). Methods Sera from 296 participants including patients with MS …
Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis.
K Regev, A Paul, B Healy, F von Glenn… - Neurology (r) …, 2016 - europepmc.org
Objective To identify circulating microRNAs (miRNAs) linked to disease stage and disability
in multiple sclerosis (MS). Methods Sera from 296 participants including patients with MS …
in multiple sclerosis (MS). Methods Sera from 296 participants including patients with MS …
[PDF][PDF] Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis
K Regev - 2016 - researchgate.net
Objective: To identify circulating microRNAs (miRNAs) linked to disease stage and disability
in multiple sclerosis (MS). Methods: Sera from 296 participants including patients with MS …
in multiple sclerosis (MS). Methods: Sera from 296 participants including patients with MS …
Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis
K Regev, A Paul, B Healy, F von Glenn… - Neurology …, 2016 - AAN Enterprises
Objective: To identify circulating microRNAs (miRNAs) linked to disease stage and disability
in multiple sclerosis (MS). Methods: Sera from 296 participants including patients with MS …
in multiple sclerosis (MS). Methods: Sera from 296 participants including patients with MS …
Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis.
K Regev, A Paul, B Healy, F von Glenn… - Neurology (r) …, 2016 - europepmc.org
Objective To identify circulating microRNAs (miRNAs) linked to disease stage and disability
in multiple sclerosis (MS). Methods Sera from 296 participants including patients with MS …
in multiple sclerosis (MS). Methods Sera from 296 participants including patients with MS …